{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:18:59Z","timestamp":1792131539475,"version":"4.4.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,7,1]]},"DOI":"10.1093\/bmb\/62.1.73","type":"journal-article","created":{"date-parts":[[2002,9,30]],"date-time":"2002-09-30T18:40:11Z","timestamp":1033411211000},"page":"73-86","source":"Crossref","is-referenced-by-count":22,"title":["Tuberculosis vaccines"],"prefix":"10.1093","volume":"62","author":[{"given":"Douglas B","family":"Young","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham R","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2002,7]]},"reference":[{"key":"key\n\t\t\t\t20180712074236_B1","doi-asserted-by":"crossref","unstructured":"Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA1999; 282: 677\u201386","DOI":"10.1001\/jama.282.7.677"},{"key":"key\n\t\t\t\t20180712074236_B2","doi-asserted-by":"crossref","unstructured":"Bloom BR, Fine PEM. The BCG experience: implications for future vaccines against tuberculosis. In: Bloom BR. (ed) Tuberculosis: Pathogenesis, Protection and Control. Washington DC: American Society for Microbiology, 1994; 531\u201357","DOI":"10.1128\/9781555818357.ch31"},{"key":"key\n\t\t\t\t20180712074236_B3","doi-asserted-by":"crossref","unstructured":"Mahairas GG, Sabo PJ, Hickey MJ, Singh DC, Stover CK. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol1996; 178: 1274\u201382","DOI":"10.1128\/jb.178.5.1274-1282.1996"},{"key":"key\n\t\t\t\t20180712074236_B4","doi-asserted-by":"crossref","unstructured":"Behr MA, Wilson MA, Gill WP et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science1999; 284: 1520\u20133","DOI":"10.1126\/science.284.5419.1520"},{"key":"key\n\t\t\t\t20180712074236_B5","doi-asserted-by":"crossref","unstructured":"Orme IM, Collins FM. Mouse model of tuberculosis. In: Bloom BR. (ed) Tuberculosis: Pathogenesis, Protection and Control. Washington DC: American Society for Microbiology, 1994; 113\u201334","DOI":"10.1128\/9781555818357.ch8"},{"key":"key\n\t\t\t\t20180712074236_B6","doi-asserted-by":"crossref","unstructured":"McMurray DN. Disease model: pulmonary tuberculosis. Trends Mol Med2001; 7: 135\u20137","DOI":"10.1016\/S1471-4914(00)01901-8"},{"key":"key\n\t\t\t\t20180712074236_B7","doi-asserted-by":"crossref","unstructured":"Buddle BM. Vaccination of cattle against Mycobacterium bovis. Tuberculosis (Edinb)2001; 81: 125\u201332","DOI":"10.1054\/tube.2000.0254"},{"key":"key\n\t\t\t\t20180712074236_B8","doi-asserted-by":"crossref","unstructured":"Langermans JA, Andersen P, van Soolingen D et al. Divergent effect of bacillus Calmette-Guerin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research. Proc Natl Acad Sci USA2001; 98: 11497\u2013502","DOI":"10.1073\/pnas.201404898"},{"key":"key\n\t\t\t\t20180712074236_B9","doi-asserted-by":"crossref","unstructured":"Colditz GA, Berkey CS, Mosteller F et al. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics1995; 96: 29\u201335","DOI":"10.1542\/peds.96.1.29"},{"key":"key\n\t\t\t\t20180712074236_B10","doi-asserted-by":"crossref","unstructured":"Black GF, Dockrell HM, Crampin AC et al. Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. J Infect Dis2001; 184: 322\u20139","DOI":"10.1086\/322042"},{"key":"key\n\t\t\t\t20180712074236_B11","unstructured":"Palmer CE, Long MW. Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. Am Rev Respir Dis1966; 94: 553\u201368"},{"key":"key\n\t\t\t\t20180712074236_B12","doi-asserted-by":"crossref","unstructured":"Karonga Prevention Trial Group. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Lancet1996; 348: 17\u201324","DOI":"10.1016\/S0140-6736(96)02166-6"},{"key":"key\n\t\t\t\t20180712074236_B13","doi-asserted-by":"crossref","unstructured":"Kristensen I, Aaby P, Jensen H. Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa. BMJ2000; 321: 1435\u20138","DOI":"10.1136\/bmj.321.7274.1435"},{"key":"key\n\t\t\t\t20180712074236_B14","doi-asserted-by":"crossref","unstructured":"Russell DG. Mycobacterium tuberculosis: here today, and here tomorrow. Nat Rev Mol Cell Biol2001; 2: 569\u201377","DOI":"10.1038\/35085034"},{"key":"key\n\t\t\t\t20180712074236_B15","doi-asserted-by":"crossref","unstructured":"Via LE, Fratti RA, McFalone M, Pagan-Ramos E, Deretic D, Deretic V. Effects of cytokines on mycobacterial phagosome maturation. J Cell Sci1998; 111: 897\u2013905","DOI":"10.1242\/jcs.111.7.897"},{"key":"key\n\t\t\t\t20180712074236_B16","doi-asserted-by":"crossref","unstructured":"Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol2001; 19: 93\u2013129","DOI":"10.1146\/annurev.immunol.19.1.93"},{"key":"key\n\t\t\t\t20180712074236_B17","doi-asserted-by":"crossref","unstructured":"Hmama Z, Gabathuler R, Jefferies WA, de Jong G, Reiner NE. Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers. J Immunol1998; 161: 4882\u201393","DOI":"10.4049\/jimmunol.161.9.4882"},{"key":"key\n\t\t\t\t20180712074236_B18","doi-asserted-by":"crossref","unstructured":"Leal IS, Smedegard B, Andersen P, Appelberg R. Failure to induce enhanced protection against tuberculosis by increasing T-cell-dependent interferon-gamma generation. Immunology2000; 104: 157\u201361","DOI":"10.1046\/j.1365-2567.2001.01305.x"},{"key":"key\n\t\t\t\t20180712074236_B19","doi-asserted-by":"crossref","unstructured":"Kaufmann SHE. How can immunology contribute to the control of tuberculosis? Nat Rev Immunol2001; 1: 20\u201330","DOI":"10.1038\/35095558"},{"key":"key\n\t\t\t\t20180712074236_B20","doi-asserted-by":"crossref","unstructured":"Orme IM, McMurray DN, Belisle JT. Tuberculosis vaccine development: recent progress. Trends Microbiol2001; 9: 115\u20138","DOI":"10.1016\/S0966-842X(00)01949-1"},{"key":"key\n\t\t\t\t20180712074236_B21","unstructured":"Rich AR. The Pathogenesis of Tuberculosis. Oxford: Blackwell, 1951"},{"key":"key\n\t\t\t\t20180712074236_B22","unstructured":"Opie EL, Aronson JD. Tubercle bacilli in latent tuberculous lesions and in lung tissue without tuberculosis lesions. Arch Pathol1927; 4: 1\u201321"},{"key":"key\n\t\t\t\t20180712074236_B23","doi-asserted-by":"crossref","unstructured":"Hernandez-Pando R, Jeyanathan M, Mengistu G et al. Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet2000; 356: 2133\u20138","DOI":"10.1016\/S0140-6736(00)03493-0"},{"key":"key\n\t\t\t\t20180712074236_B24","doi-asserted-by":"crossref","unstructured":"Guleria L, Teitelbaum R, McAdam RA, Kalpana G, Jacobs Jr WR, Bloom BR. Auxotrophic vaccines for tuberculosis. Nat Med1996; 2: 334\u20137","DOI":"10.1038\/nm0396-334"},{"key":"key\n\t\t\t\t20180712074236_B25","doi-asserted-by":"crossref","unstructured":"Chambers MA, Williams A, Gavier-Widen D et al. Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin. Infect Immun2000; 68: 7094\u20139","DOI":"10.1128\/IAI.68.12.7094-7099.2000"},{"key":"key\n\t\t\t\t20180712074236_B26","doi-asserted-by":"crossref","unstructured":"Murray PJ, Aldovini A, Young RA. Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guerin strains that secrete cytokines. Proc Natl Acad Sci USA1996; 93: 934\u20139","DOI":"10.1073\/pnas.93.2.934"},{"key":"key\n\t\t\t\t20180712074236_B27","doi-asserted-by":"crossref","unstructured":"Marshall BG, Wangoo A, O'Gaora P, Cook HT, Shaw RJ, Young DB. Enhanced antimycobacterial response to recombinant Mycobacterium bovis BCG expressing latency-associated peptide. Infect Immun2001; 69: 6676\u201382","DOI":"10.1128\/IAI.69.11.6676-6682.2001"},{"key":"key\n\t\t\t\t20180712074236_B28","doi-asserted-by":"crossref","unstructured":"Horwitz MA, Harth G, Dillon BJ, Maslesa-Galic S. Recombinant bacillus Calmette-Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc Natl Acad Sci USA2000; 97: 13853\u20138","DOI":"10.1073\/pnas.250480397"},{"key":"key\n\t\t\t\t20180712074236_B29","doi-asserted-by":"crossref","unstructured":"Stewart GR, Snewin VA, Walzl G et al. Overexpression of heat-shock proteins reduces survival of Mycobacterium tuberculosis in the chronic phase of infection. Nat Med2001; 7: 732\u20137","DOI":"10.1038\/89113"},{"key":"key\n\t\t\t\t20180712074236_B30","doi-asserted-by":"crossref","unstructured":"Hess J, Miko D, Catic A, Lehmensiek V, Russell DG, Kaufmann SH. Mycobacterium bovis bacille Calmette-Guerin strains secreting listeriolysin of Listeria monocytogenes. Proc Natl Acad Sci USA1998; 95: 5299\u2013304","DOI":"10.1073\/pnas.95.9.5299"},{"key":"key\n\t\t\t\t20180712074236_B31","doi-asserted-by":"crossref","unstructured":"Smith DA, Parish T, Stoker NG, Bancroft GJ. Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates. Infect Immun2001; 69: 1142\u201350","DOI":"10.1128\/IAI.69.2.1442-1150.2001"},{"key":"key\n\t\t\t\t20180712074236_B32","doi-asserted-by":"crossref","unstructured":"Camacho LR, Ensergueix D, Perez E, Gicquel B, Guilhot C. Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol Microbiol1999; 34: 257\u201367","DOI":"10.1046\/j.1365-2958.1999.01593.x"},{"key":"key\n\t\t\t\t20180712074236_B33","doi-asserted-by":"crossref","unstructured":"Cox JS, Chen B, McNeil M, Jacobs Jr WR. Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature1999; 402: 79\u201383","DOI":"10.1038\/47042"},{"key":"key\n\t\t\t\t20180712074236_B34","doi-asserted-by":"crossref","unstructured":"Glickman MS, Cox JS, Jacobs Jr WR. A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. Mol Cell2000; 5: 717\u201327","DOI":"10.1016\/S1097-2765(00)80250-6"},{"key":"key\n\t\t\t\t20180712074236_B35","doi-asserted-by":"crossref","unstructured":"Perez E, Samper S, Bordas Y, Guilhot C, Gicquel B, Martin C. An essential role for phoP in Mycobacterium tuberculosis virulence. Mol Microbiol2001; 41: 179\u201387","DOI":"10.1046\/j.1365-2958.2001.02500.x"},{"key":"key\n\t\t\t\t20180712074236_B36","doi-asserted-by":"crossref","unstructured":"Andersen P. TB vaccines: progress and problems. Trends Immunol2001; 3: 160\u20138","DOI":"10.1016\/S1471-4906(01)01865-8"},{"key":"key\n\t\t\t\t20180712074236_B37","doi-asserted-by":"crossref","unstructured":"Coler RN, Campos-Neto A, Ovendale P et al. Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis. J Immunol2001; 166: 6227\u201335","DOI":"10.4049\/jimmunol.166.10.6227"},{"key":"key\n\t\t\t\t20180712074236_B38","doi-asserted-by":"crossref","unstructured":"Skeiky YA, Ovendale PJ, Jen S et al. T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection. J Immunol2000; 165: 7140\u20139","DOI":"10.4049\/jimmunol.165.12.7140"},{"key":"key\n\t\t\t\t20180712074236_B39","doi-asserted-by":"crossref","unstructured":"Belisle JT, Vissa VD, Sievert T, Takayama K, Brennan PJ, Besra GS. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science1997; 276: 1420\u20132","DOI":"10.1126\/science.276.5317.1420"},{"key":"key\n\t\t\t\t20180712074236_B40","doi-asserted-by":"crossref","unstructured":"Alderson MR, T. Bement T, Day CH et al. Expression cloning of an immunodominant family of Mycobacterium tuberculosis antigens using human CD4(+) T cells. J Exp Med2000; 191: 551\u201360","DOI":"10.1084\/jem.191.3.551"},{"key":"key\n\t\t\t\t20180712074236_B41","doi-asserted-by":"crossref","unstructured":"Weinrich Olsen A, van Pinxteren LA, Meng Okkels L, Birk Rasmussen P, Andersen P. Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. Infect Immun2001; 69: 2773\u20138","DOI":"10.1128\/IAI.69.5.2773-2778.2001"},{"key":"key\n\t\t\t\t20180712074236_B42","doi-asserted-by":"crossref","unstructured":"Huygen K, Content J, Denis O et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med1996; 2: 893\u20138","DOI":"10.1038\/nm0896-893"},{"key":"key\n\t\t\t\t20180712074236_B43","doi-asserted-by":"crossref","unstructured":"Baldwin SL, D'Souza C, Roberts AD et al. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect Immun1998; 66: 2951\u20139","DOI":"10.1128\/IAI.66.6.2951-2959.1998"},{"key":"key\n\t\t\t\t20180712074236_B44","doi-asserted-by":"crossref","unstructured":"McShane H, Brookes R, Gilbert SC, Hill AV. Enhanced immunogenicity of CD4(+) T-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis. Infect Immun2001; 69: 681\u20136","DOI":"10.1128\/IAI.69.2.681-686.2001"},{"key":"key\n\t\t\t\t20180712074236_B45","doi-asserted-by":"crossref","unstructured":"Olsen AW, Hansen PR, Holm A, Andersen P. Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. Eur J Immunol2000; 30: 1724\u201332","DOI":"10.1002\/1521-4141(200006)30:6<1724::AID-IMMU1724>3.0.CO;2-A"},{"key":"key\n\t\t\t\t20180712074236_B46","doi-asserted-by":"crossref","unstructured":"Lowrie DB, Tascon RE, Bonato VL et al. Therapy of tuberculosis in mice by DNA vaccination. Nature1999; 400: 269\u201371","DOI":"10.1038\/22326"},{"key":"key\n\t\t\t\t20180712074236_B47","unstructured":"BCG vaccination: should we give a second dose in childhood? http:\/\/www.liv.ac.uk\/lstm\/ihm2-3.html"},{"key":"key\n\t\t\t\t20180712074236_B48","unstructured":"BCG Clinical Trial Western Cape Region, South Africa. http:\/\/www.sequellafoundation.org\/bcgwcrsa.asp"},{"key":"key\n\t\t\t\t20180712074236_B49","doi-asserted-by":"crossref","unstructured":"Comstock GW. Simple, practical ways to assess the protective efficacy of a new tuberculosis vaccine. Clin Infect Dis2000; 30 (Suppl 3): S250\u20133","DOI":"10.1086\/313870"},{"key":"key\n\t\t\t\t20180712074236_B50","doi-asserted-by":"crossref","unstructured":"Durban Immunotherapy Group. Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trial. Lancet1999; 354: 116\u20139","DOI":"10.1016\/S0140-6736(98)10448-8"}],"container-title":["British Medical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bmb\/article-pdf\/62\/1\/73\/25151773\/73.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T19:05:19Z","timestamp":1682363119000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bmb\/article\/62\/1\/73\/281127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,1]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2002,7]]},"published-print":{"date-parts":[[2002,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/bmb\/62.1.73","relation":{},"ISSN":["1471-8391","0007-1420"],"issn-type":[{"value":"1471-8391","type":"electronic"},{"value":"0007-1420","type":"print"}],"subject":[],"published-other":{"date-parts":[[2002,7]]},"published":{"date-parts":[[2002,7,1]]}}}